TELUS Reports C$660 Million Loss, Targets C$900 Million Savings
TELUS Corporation reported a Q3 2026 net loss of C$660 million due to a C$800 million goodwill impairment. Revenue declined 2% to C$5.026 billion, and adjusted EBITDA fell 5% to C$1.760 billion. The company aims for C$900 million in annualized savings by 2028 and plans to monetize assets in TELUS Health and TELUS Agriculture & Consumer Goods.
How this was made
The 30-second read
Why it matters
The earnings miss and goodwill impairment highlight execution risks in TELUS Health, while the announced savings may mitigate future cash‑flow concerns.
Market read
The loss and impairment are material for investors; the stock may react negatively in the short term.
What to watch
Potential upside from monetizing TELUS Health and Agriculture assets not yet quantified.
Background
TELUS is a major Canadian telecom and technology provider with diversified services including health and agriculture tech.
Ticker impact
TELUS reported a Q3 2026 net loss of C$660 million and a C$800 million goodwill impairment, announcing a C$900 million cost‑saving program.
downward pressure as investors price in the loss and higher leverage
First‑report earnings loss with sizable impairment and a large cost‑cut plan signals short‑term earnings weakness.
Market effects
Telecom sector may see broader scrutiny on cost structures and health‑tech exposures.
Canadian market could face modest pullback on telecom exposure.
Limited; primarily affects Canadian telecom and related tech investors.
Counterpoint
Cost‑saving program could improve margins over the next few years, offering a buying opportunity at a discounted price.
Key entities
- companyTELUS Corporation
Canadian telecom and technology firm reporting Q3 loss.
